Hormone Replacement Therapy for Women and What You Should Know

Hormone replacement therapy for women replaces the estrogen the body stops producing at menopause, and it comes in four distinct types rather than one treatment. Which type suits a woman depends on whether she still has a uterus, which symptoms bother her most, her age, and how long ago her periods stopped.

Below we cover the four types and what each one treats, who benefits most, who should avoid it, what the 2025 and 2026 labeling changes actually changed, what "natural" hormone therapy means, and how to work through the decision.

What Is Hormone Replacement Therapy for Women?

Hormone replacement therapy for women is medicine containing female hormones, taken to replace the estrogen the body stops making after menopause. Mayo Clinic defines it that way and notes the treatment is now more often called menopausal hormone therapy, because it replaces only a fraction of what the ovaries once produced.

Menopause is the trigger. The U.S. Food and Drug Administration describes menopause as the permanent end of menstrual periods, usually occurring between ages 45 and 55, at which point the body produces less estrogen and progesterone. Lower levels of those two hormones drive hot flashes, night sweats, vaginal dryness, painful sex, and bone thinning.

Replacement is not the same as restoration. The goal is relieving symptoms and protecting bone rather than returning hormone levels to what they were at 30, which is why the standard approach uses the lowest dose that works. A hormonal imbalance can be corrected in more than one direction, and overshooting produces its own problems.

Two hormones, several delivery routes, and one anatomical question produce the four types described next.

What Are the Four Types of Hormone Replacement Therapy?

The four types of hormone replacement therapy are systemic combination therapy, systemic estrogen-alone therapy, systemic progestogen-alone therapy, and topical vaginal estrogen therapy. That is the FDA's own taxonomy, and it is the most precise framework available.

Systemic means the hormone enters the bloodstream and travels throughout the body. Topical vaginal means the hormone acts mainly where it is applied. That single distinction determines which symptoms a given product can treat.

TypeWhat It ContainsWho It Is Generally ForAvailable FormsWhat It TreatsSystemic combination therapyEstrogen plus progesterone or a progestinWomen who still have a uterusMost commonly pills or skin patchesHot flashes, night sweats, and other whole-body symptomsSystemic estrogen-alone therapyEstrogen onlyUsually women who have had a hysterectomyPills, skin patches, spray, gel, vaginal ringHot flashes, night sweats, and other whole-body symptomsSystemic progestogen-alone therapyProgesterone or a progestin onlyWomen with a uterus who are taking systemic estrogenPillsAdded to protect the lining of the uterusTopical vaginal estrogen therapyLow-dose estrogenWomen whose main symptoms are vaginal or urinaryCream, tablet, insert, ringVaginal dryness, painful sex, and some urinary symptoms

Sources: U.S. Food and Drug Administration consumer update on menopausal hormone therapy; Mayo Clinic; Cleveland Clinic.

What Is the Difference Between Systemic and Vaginal Estrogen?

The difference between systemic and vaginal estrogen is dose and reach. Systemic estrogen typically contains more estrogen, is absorbed by the whole body, and treats the full range of menopause symptoms. Low-dose vaginal estrogen contains less, limits how much estrogen the body absorbs, and treats vaginal and urinary symptoms only, according to Mayo Clinic.

Reach explains a common disappointment. A woman using vaginal cream for dryness should not expect her hot flashes to improve, because the product was never designed to act beyond the tissue it touches. Mayo Clinic notes that when vaginal symptoms are the only complaint, a low-dose vaginal product is usually a better choice than a pill or a patch.

Why Do Women Need Progesterone With Estrogen?

Women who still have a uterus need progesterone with estrogen because estrogen taken alone thickens the lining of the uterus, which raises the risk of endometrial cancer. Mayo Clinic, Cleveland Clinic, and the FDA all state this rule identically, and it is the single most important safety fact in the topic.

Estrogen taken alone thickens the endometrium, the lining of the uterus. A thickened endometrium can progress to an overgrowth of cells, and that overgrowth is what can develop into cancer. Endometrial protection is the entire job of the progestogen component, which is why the FDA lists progestogen-alone therapy as a category in its own right rather than folding it into combination therapy.

Anatomy decides the requirement. Women who have had a hysterectomy usually do not need a progestogen, since there is no lining to protect, and Cleveland Clinic notes that estrogen taken alone carries fewer long-term risks than combination therapy. Women with a uterus taking systemic estrogen need both.

This rule is also why one warning survived the recent labeling changes while others did not.

Is Hormone Replacement Therapy Safe for Women?

Hormone replacement therapy is considered reasonably safe for most healthy women who begin it before age 60 or within ten years of menopause, and the FDA revised its labeling in 2025 and 2026 to reflect that. Safety depends on the type, the route, the dose, the duration, and the woman's own health history.

The labeling change was substantial. The FDA requested that manufacturers of all hormone therapy products containing estrogen or progestogen remove risk statements about cardiovascular disease, breast cancer, and probable dementia from the boxed warning, which is the agency's most prominent safety warning. Several companies have already made those changes and the FDA has approved them.

Two details matter and are widely misreported. The FDA did not request removal of cardiovascular disease and breast cancer risks from the Warnings and Precautions section of the labeling, so those risks remain on the label in a different place. The agency also is not requesting removal of the boxed warning for endometrial cancer on systemic estrogen-alone products, for the reason described in the previous section.

The agency stated its reasoning plainly. Millions of women avoided hormone therapy from the early 2000s onward because of fears about cancer and heart disease, and the FDA describes the labeling changes as giving women and their providers updated information so they can make informed decisions. Some clinicians have argued the change went further than the evidence supports for systemic products, so this remains an active discussion rather than a settled one.

What has not changed is that risks vary by person. Mayo Clinic lists heart disease, stroke, blood clots, breast cancer, gallbladder disease, and endometrial cancer among the possible risks, and notes that the level of risk depends on age, type of therapy, and health history.

Who Benefits Most From Hormone Replacement Therapy?

The women who benefit most from hormone replacement therapy are those with moderate to severe hot flashes, those with bothersome vaginal or bladder symptoms, those who need protection against bone loss, and those who reached menopause early or have low estrogen for another reason. Mayo Clinic identifies these four groups and notes the benefits may outweigh the risks when treatment starts before age 60 or within ten years of menopause.

Effect size is what makes the first group the clearest case. Combined estrogen and progestin regimens, or estrogen alone in women who have had a hysterectomy, reduce the frequency and severity of hot flashes and night sweats by around 75 percent, according to a clinical review in CMAJ. Hormone therapy was originally approved on evidence showing 70 to 90 percent reduction in hot flash frequency and severity against a 20 to 30 percent placebo effect.

Comparison sharpens the picture further. Antidepressants prescribed for hot flashes achieve roughly half the effect of hormone therapy, in the range of 40 to 50 percent reduction. Nothing else available performs as well for this specific symptom, which is why Mayo Clinic calls systemic estrogen the most effective treatment for hot flashes and night sweats.

Benefits documented across the research include:

• Relief from hot flashes and night sweats, the best-supported use
• Improvement in vaginal dryness, itching, burning, and pain with intercourse
• Help with bladder symptoms including frequency, urgency, leaking, and recurrent urinary tract infections
• Protection against bone loss and reduced fracture risk
• Better sleep in women whose nights are broken by night sweats
• Improved sexual function
• Lower diabetes risk and reduced colorectal cancer risk on combination therapy

An umbrella review in PLOS Medicine covering 60 systematic reviews and 102 health outcomes found consistent or highly suggestive randomized evidence of benefit for vasomotor symptoms, vaginal atrophy, sexual function, fractures, diabetes, and colorectal cancer. That same review found observational data associating hormone therapy with lower all-cause mortality at a relative risk of 0.89, while randomized trials showed no effect at 0.99, which is a useful reminder that observational and randomized evidence often disagree. Women whose main interest is symptom relief can read more about menopause symptom relief separately.

Does HRT Help With Bone Loss?

HRT does help with bone loss, and the fracture data is among the strongest evidence in the field. The Women's Health Initiative reported a 34 percent reduction in hip fractures, a 34 percent reduction in vertebral fractures, and a 23 percent reduction in other osteoporotic fractures compared with women not taking hormone therapy.

Pooled analyses agree. A meta-analysis of 28 studies including 33,426 participants found hormone therapy reduced hip fracture risk by 28 percent, vertebral fracture risk by 37 percent, and all fractures by 26 percent. A separate meta-analysis of 22 randomized trials found a 35 percent reduction in non-vertebral fractures among women who began therapy before age 60, with the benefit weakening when therapy started later.

Timing appears in that last figure, and it appears again in the dementia question.

Is There a Link Between HRT and Dementia?

The link between HRT and dementia comes from one study of women aged 65 and older, and the FDA removed the probable dementia statement from the boxed warning after reviewing the fuller evidence. The age of the women studied turns out to be the whole story.

The Women's Health Initiative Memory Study enrolled about 7,500 women aged 65 and older. Among those taking combined estrogen and progestin, 45 women per 10,000 developed dementia each year compared with 22 per 10,000 on placebo, an excess of 23 cases per 10,000 women annually. In the estrogen-alone arm of 2,947 women who had undergone hysterectomy, probable dementia occurred at 37 versus 25 cases per 10,000 women-years, a difference whose confidence interval crossed the line of no effect.

Participant age is the detail that reframes those numbers. Women in that study were on average about 20 years past menopause when they started treatment. A younger companion study, following roughly 1,300 women who had enrolled at ages 50 to 54, found no effect in either direction on multiple cognitive domains when tested years later.

Two further trials support the same reading. The Kronos Early Estrogen Prevention Study and the Early Versus Late Intervention Trial with Estradiol both found no cognitive benefit and no cognitive decline when hormone therapy began at or near menopause. Taken together, the evidence says starting hormone therapy at 65 after two decades without estrogen is a different proposition from starting it at 51, and it does not show that hormone therapy protects the brain either. Women concerned about mood changes or thinking clearly during this transition are better served by addressing sleep, thyroid function, and nutrient status alongside any hormone decision.

What Age Is Too Late to Take Estrogen?

There is no fixed age that is too late to take estrogen, though the risk and benefit balance shifts against systemic therapy after age 60 or more than ten years past menopause. Mayo Clinic states that starting at 60 or older, or more than ten years after menopause, increases the risk of serious complications, while starting before 60 or within ten years may put the benefits ahead of the risks.

The reason is vascular rather than arbitrary. Blood vessels change over years without estrogen, and introducing systemic estrogen into vessels that have already accumulated changes behaves differently than introducing it earlier. That mechanism also explains the dementia findings above and the weakening fracture benefit after 60.

Women over 60 are not out of options. Low-dose vaginal estrogen delivers very little hormone into the bloodstream and remains appropriate for vaginal and urinary symptoms at any age. For women who need systemic therapy later, transdermal delivery avoids the liver pass that raises clotting proteins, which is the specific risk that concerns clinicians most in this group.

Age also runs the other direction. Mayo Clinic notes that women who go through menopause or have their ovaries removed before 45, or whose ovaries stop working before 40, may benefit from hormone therapy because they would otherwise have low estrogen for far longer than usual, with higher risks of osteoporosis, heart disease, dementia, and mood changes. For that group, healthy aging planning often includes hormone therapy rather than avoiding it, and Mayo notes women younger than 45 need enough estrogen to protect against the long-term effects of estrogen deficiency.

What Disqualifies You From HRT?

What disqualifies you from HRT is a history of breast, ovarian, or uterine cancer, unexplained vaginal bleeding, a history of blood clots or high clot risk, a history of stroke, heart attack, or elevated cardiovascular risk, pregnancy, and gallbladder or liver disease. Cleveland Clinic lists each of these as reasons a provider may decide hormone therapy is not appropriate.

Some of these are absolute and some are situational. An active hormone-sensitive cancer is a clear reason to avoid systemic hormones. Elevated clot risk, by contrast, may point toward transdermal rather than oral delivery instead of ruling out treatment altogether, since the two routes carry very different clot profiles. Smoking sits in the same category, because the combination of estrogen and cigarettes raises clot and stroke risk more than either alone.

Unexplained bleeding is a special case worth naming. Bleeding that has not been evaluated needs a diagnosis before hormones enter the picture, since hormone therapy can obscure the very finding a provider is looking for.

How Long Does HRT Take to Work?

HRT takes a few weeks to begin working for hot flashes and night sweats, and longer for other symptoms. Vaginal tissue changes typically need several weeks to a few months of consistent use before dryness improves meaningfully. Bone benefits accrue over years and are measured rather than felt.

Early weeks can also bring side effects that settle. Breast tenderness, headaches, bloating, and irregular spotting are common in the first months and usually improve within about three months, which is why a three-month review is standard rather than an early abandonment.

Do You Gain Weight When You First Start HRT?

Most women do not gain weight from starting HRT, and there is little evidence that most types of hormone therapy cause weight gain. Weight often rises during menopause and with age whether or not a woman takes hormones.

Fluid retention accounts for much of the early impression. Mild swelling in the hands, feet, or lower legs is a recognized effect of estrogen therapy, and it registers on a scale as added pounds without any change in body fat. Fluid shifts of that kind typically settle within the first months alongside the other early effects.

The underlying change is distribution rather than total. Estrogen influences where the body stores fat, so falling estrogen shifts storage toward the abdomen regardless of treatment, and declining muscle mass through midlife lowers the calories burned at rest. Persistent weight changes in this period usually involve thyroid function, insulin sensitivity, sleep, and muscle together, and hormone therapy is one input among several.

What Is Natural Hormone Replacement Therapy?

Natural hormone replacement therapy usually refers to bioidentical hormones, which are compounds molecularly identical to the estrogen and progesterone the body produces, though the term is also used loosely for herbal supplements. Those two meanings have very different evidence behind them, so the distinction matters.

Bioidentical is a description of molecular structure rather than a brand or a category of regulation. Estradiol and micronized progesterone are both bioidentical and both available in FDA-approved prescription forms, which means a woman can have bioidentical hormones without stepping outside the approved products the FDA describes. Cleveland Clinic makes the same point, noting bioidentical hormones are a type of hormone replacement therapy that more closely matches the body's own estrogen and progesterone, with multiple FDA-approved options available.

Structure has measurable consequences. In the ESTHER study, micronized progesterone carried a venous clot odds ratio of 0.7, showing no increase, while norpregnane derivatives carried close to a fourfold increase at 3.9. Comparable differences appear between estradiol and conjugated equine estrogen. Choosing among preparations is a safety decision supported by data rather than a preference, and a naturopathic medicine approach treats it as one.

Herbal supplements marketed for menopause are a separate matter. Comparative summaries have found nutraceuticals including black cohosh performing no differently from placebo for hot flashes, well below the 70 to 90 percent reduction seen with hormone therapy. Supplements can have a role in a broader plan, and they are not a substitute for hormones when hormones are what a woman needs.

Are Compounded Bioidentical Hormones the Same as FDA-Approved Ones?

Compounded bioidentical hormones are not the same as FDA-approved ones, because compounded preparations are mixed by a pharmacy for an individual rather than manufactured and tested as an approved product. Cleveland Clinic notes that compounded hormones are less well studied than approved options and that some providers do not recommend them for that reason.

Our position is straightforward. Our bioidentical hormone therapy protocols favor delivery methods that keep levels steady and allow dose adjustment, and we do not recommend hormone pellets, because a pellet cannot be adjusted once it is placed and releases unevenly across its lifespan. Where an approved bioidentical product fits a woman's needs, that is the simpler and better-evidenced choice.

What Hormones Are Used in HRT for Women?

The hormones used in HRT for women are estrogen and progesterone or a progestin, with testosterone and thyroid hormone sometimes addressed alongside them when testing shows a reason. Delivery route matters as much as the hormone itself.

The hormones and routes in common use include:

• Estradiol, the main form of estrogen, available as a pill, patch, gel, spray, vaginal ring, cream, or vaginal tablet
• Conjugated estrogens, an older estrogen preparation taken as a pill, which carries a different clot profile than estradiol
• Micronized progesterone, a bioidentical progesterone taken as a capsule, used for endometrial protection
• Progestins, synthetic compounds that act like progesterone, available in pills, patches, and an intrauterine device
• Low-dose vaginal estrogen, delivered as a cream, tablet, insert, or ring for vaginal and urinary symptoms
• Testosterone, which some women are prescribed at physiological doses, most often for low sexual desire

Thyroid hormone belongs in the same conversation without being part of hormone replacement therapy itself. Hypothyroidism produces fatigue, weight change, brain fog, and irregular cycles that overlap heavily with menopause, so thyroid hormones are worth assessing before attributing every symptom to estrogen. Getting that attribution wrong is how a treatable problem goes unaddressed.

Do You Need Testing Before Starting HRT?

You do not need a hormone test to diagnose menopause, and testing before starting hormone therapy is still worth doing to establish a baseline and rule out other explanations for your symptoms. Those are two separate purposes and they get confused often.

Diagnosis rarely requires labs. Menopause is confirmed by 12 consecutive months without a period, and perimenopausal hormone levels fluctuate too much for a single draw to be reliable. A number from one morning does not describe a moving target.

Exclusion is where testing earns its place. Thyroid dysfunction, iron deficiency, insulin resistance, and vitamin D deficiency all produce symptoms that resemble menopause, and each is treatable once identified. Baseline measurements also make later changes interpretable, which matters for blood pressure, lipids, and liver function once therapy begins. At our Bingham Farms office we run this workup deeper than a standard hormone panel.

Our advanced lab testing examines hormone metabolites, liver detoxification pathways, full thyroid function, nutrient status, inflammatory markers, and genetic factors affecting how a woman processes hormones. Two women with the same symptoms often turn out to have different drivers, and that is what shapes which of the four types and which route fits.

Ongoing monitoring follows the same logic. Mayo Clinic recommends regular follow-up to confirm benefits still outweigh risks, along with continued mammograms, blood pressure measurement, and cervical cancer screening.

Review intervals are what make a long course workable. Our hormone therapy protocols are built around that kind of scheduled reassessment rather than a single prescription.

Why Do I Feel So Good on Estrogen?

Women feel good on estrogen because the hormone acts on temperature regulation, sleep, mood, vaginal tissue, and energy at the same time, and because relief from several symptoms at once is felt as a general improvement. The size of the effect explains the intensity of the response.

Temperature regulation improves first and most measurably. Hot flashes drop by roughly 75 percent in frequency and severity on hormone therapy, and a woman who had been waking several times a night drenched gets her nights back. Sleep improvement then compounds into daytime energy, concentration, and mood, since fragmented sleep degrades all three.

Sleep is worth separating from the flashes themselves. Some women find their nights improve for reasons beyond night sweats, and others find sleep remains disrupted after flashes settle, which points elsewhere. Persistent sleep quality problems deserve their own attention rather than being folded into the hormone decision.

Expectations deserve calibration alongside the enthusiasm. Hormone therapy treats symptoms of estrogen loss well. It is not a general-purpose energy or anti-aging treatment, and the research does not support using it to prevent chronic disease in women without symptoms.

Can You Stay on HRT for Life?

There is no fixed limit on how long you can stay on HRT, and most women take it for five years or less. Cleveland Clinic gives that figure while noting there is no set length of time, with duration depending on symptom severity, the type of therapy, and personal preference.

Duration interacts with one specific risk. Breast cancer risk on combination therapy typically does not increase until after about five years of use, and Cleveland Clinic puts the eventual increase at less than 1 in 1,000. That timeline is what makes five years a natural review point rather than a deadline.

Longer courses are reasonable in specific situations. Mayo Clinic notes that women with lasting symptoms that harm quality of life may be recommended longer treatment, and that women younger than 45 need enough estrogen to protect against the effects of early estrogen loss. Low-dose vaginal estrogen is often continued indefinitely, since systemic absorption is minimal.

What makes any duration workable is review. Continuing therapy is a series of decisions made with a provider rather than one decision made at the start.

How Do You Decide If Hormone Replacement Therapy Is Right for You?

You decide if hormone replacement therapy is right for you by identifying which symptoms actually bother you, confirming what is causing them, checking your history against the reasons to avoid treatment, and then choosing the type and route that match. Working in that order avoids most of the disappointment women report with hormone therapy.

A workable sequence looks like this:

1. Write down your three most disruptive symptoms and how much each affects your daily life. Treatment choice follows from which symptoms matter, not from a general sense of feeling off.
2. Get tested for the conditions that mimic menopause, including thyroid function, iron status, blood sugar, and vitamin D.
3. Review your medical history against the reasons to avoid hormone therapy, including cancer history, clot history, cardiovascular events, liver and gallbladder disease, and unexplained bleeding.
4. Note where you are relative to menopause, since starting before age 60 or within ten years carries a different balance than starting later.
5. Match the type to the symptoms. Vaginal symptoms alone point toward low-dose vaginal estrogen; whole-body symptoms point toward systemic therapy, with a progestogen added if you still have a uterus.
6. Discuss route and preparation, since oral and transdermal delivery differ measurably on clot risk and preparations differ from each other.
7. Agree on a review point, typically around three months, and on which measurements will be tracked.

Most of the women we see across Oakland County arrive somewhere in the middle of that list, often having been told their symptoms were simply age. Our approach to bioidentical hormones starts by finishing the diagnostic work first, because a hormone prescription built on an incomplete picture tends to underperform.

Frequently Asked Questions

What Are the Alternatives If You Can't Take HRT?

The alternatives if you cannot take HRT include non-hormonal prescription medications for hot flashes, cognitive behavioral therapy, clinical hypnosis, and weight loss, along with vaginal moisturizers and lubricants for dryness. Mayo Clinic lists these and notes prescription options such as ospemifene and prasterone for painful intercourse and other vaginal symptoms. The FDA has approved three non-hormone therapies for women who cannot or choose not to take hormones.

Can You Take HRT After a Hysterectomy?

You can take HRT after a hysterectomy, and estrogen-alone therapy is typically what providers recommend in that situation. Cleveland Clinic explains that estrogen taken alone carries fewer long-term risks than combination therapy, and a progestogen is generally unnecessary because there is no uterine lining to protect.

Is HRT the Same as Bioidentical Hormone Therapy?

Bioidentical hormone therapy is a type of HRT rather than a different treatment. The term describes hormones that are molecularly identical to the body's own, including estradiol and micronized progesterone, both of which are available in FDA-approved forms. Cleveland Clinic notes that compounded bioidentical preparations are less well studied than approved products.

Do You Need HRT If Your Symptoms Are Mild?

You do not need HRT if your symptoms are mild, and many women manage well without it. Cleveland Clinic notes that many people find their symptoms mild enough that lifestyle changes alone make a meaningful difference. Hormone therapy is not recommended for preventing chronic disease in women without symptoms.

Does HRT Help With Sleep?

HRT does help with sleep for many women, particularly when night sweats are what is waking them. Cleveland Clinic lists improved sleep among the benefits. Sleep that stays disrupted after hot flashes settle usually has another cause worth investigating, since sleep problems in midlife often involve more than hormones.

Can You Switch From Pills to a Patch?

You can switch from pills to a patch, and the NHS gives that exact switch as an example of how a provider adjusts treatment when side effects are bothersome. The switch also changes clot risk, because oral estrogen passes through the liver first and raises clotting proteins while transdermal estrogen does not. Any change should be made with the prescriber rather than independently.

The Bottom Line

Hormone replacement therapy for women is four treatments rather than one, and most confusion about it comes from treating them as interchangeable. Whether you still have a uterus determines whether you need a progestogen. Which symptoms bother you determines whether you need systemic or vaginal delivery. How long ago your periods stopped shifts the balance of risk and benefit. Which preparation and which route you use changes the clot profile measurably. For hot flashes, nothing available works as well, with roughly 75 percent reduction in frequency and severity, and the fracture data is nearly as strong.

The 2025 and 2026 labeling changes moved cardiovascular, breast cancer, and dementia language out of the boxed warning while leaving those risks on the label elsewhere and keeping the endometrial cancer warning on estrogen-alone products. That shift makes the conversation easier to have, and it does not replace the workup. The most common mistake we see is not choosing hormone therapy or avoiding it, but starting it before anyone has confirmed what is actually causing the symptoms.

If you are weighing this decision and want a clear picture before you commit to anything, we would be glad to work through it with you. Cutler Integrative Medicine has helped women navigate hormone decisions for over fifteen years. Our practice is based in Bingham Farms.

You are welcome to schedule a consultation whenever the timing suits you.